1. Home
  2. LGIH vs PSNL Comparison

LGIH vs PSNL Comparison

Compare LGIH & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

HOLD

Current Price

$50.78

Market Cap

1.3B

ML Signal

HOLD

Logo Personalis Inc.

PSNL

Personalis Inc.

HOLD

Current Price

$16.10

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGIH
PSNL
Founded
2003
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
LGIH
PSNL
Price
$50.78
$16.10
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$75.90
$12.20
AVG Volume (30 Days)
222.5K
3.7M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.58
EPS
1.25
N/A
Revenue
$1,705,504,000.00
$69,648,000.00
Revenue This Year
$2.32
$15.34
Revenue Next Year
$17.94
$41.46
P/E Ratio
$39.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$33.55
$4.96
52 Week High
$66.25
$18.89

Technical Indicators

Market Signals
Indicator
LGIH
PSNL
Relative Strength Index (RSI) 39.08 54.47
Support Level $46.17 $7.62
Resistance Level $55.62 $16.39
Average True Range (ATR) 1.93 0.61
MACD -0.68 -0.21
Stochastic Oscillator 23.60 17.68

Price Performance

Historical Comparison
LGIH
PSNL

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company's current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under the LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company has seven operating segments: West, Northwest, Central, Midwest, Florida, Southeast, and Mid-Atlantic. The majority of the revenue is generated from the Central division segment.

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Share on Social Networks: